Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Decreased fibrinolytic capacity has been suggested to accelerate the process of arterial atherogenesis by facilitating thrombosis and fibrin deposition within developing atherosclerotic lesions. Type 1 plasminogen activator inhibitor (PAI-1) is the primary inhibitor of tissue-type plasminogen activa...

Description complète

Détails bibliographiques

Publié dans:	Proc Natl Acad Sci U S A
Auteurs principaux:	Schneiderman, J, Sawdey, M S, Keeton, M R, Bordin, G M, Bernstein, E F, Dilley, R B, Loskutoff, D J
Format:	Artigo
Langue:	Inglês
Publié:	National Academy of Sciences 1992
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC49632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1495992/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.15.6998
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!